{"disease":{"id":"antineutrophil-cytoplasmic-antibody-anca-associated-nephritis-aagn","name":"antineutrophil cytoplasmic antibody anca associated nephritis aagn"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06656962","title":"The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}